Comparison of Three Cardioverter Defibrillator Implantation Techniques: Initial Results with Transvenous Pectoral Implantation
- 1 July 1996
- journal article
- research article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 19 (7) , 1061-1069
- https://doi.org/10.1111/j.1540-8159.1996.tb03414.x
Abstract
A total of 121 patients underwent epicardial (n = 32), transvenous abdominal (n = 30), and transvenous pectoral (n = 59) ICD implants. Perioperative complications were defined as those occurring within 30 days after surgery. Hospital costs were calculated with $750 per day as a fixed charge. Duration of surgery was the time between the first skin incision and the last skin suture. Severe perioperative complications that were life-threatening or required surgical intervention occurred in the epicardial (6%) and transvenous (10%) abdominal groups, but not in the pectoral group. Perioperative mortality occurred only in the epicardial abdominal group, predominantly in patients with concomitant surgery (18%), and in 5% of patients without concomitant surgery. The duration of surgery was significantly shorter for transvenous pectoral implantation (58 +/- 15 min, P < 0.05) compared to transvenous abdominal implantation (115 +/- 38 min). Epicardial abdominal ICD implantation had the longest procedure time (154 +/- 31 min). The postimplant hospital length of stay was significantly shorter for pectoral implantation (5 +/- 3 days, P < 0.05) compared to transvenous (13 +/- 5) and epicardial (19 +/- 5) abdominal implantation. Total hospitalization costs significantly decreased in the pectoral implantation group ($4,068 +/- $2,099 for the pectoral group vs $14,887 +/- $4,415 and $9,975 +/- $3,657 for the epicardial and the transvenous abdominal group, respectively, P < 0.05). These initial results demonstrate the advantage of transvenous pectoral ICD implantation in terms of perioperative complications, procedure time, hospital length of stay, and hospitalization costs.Keywords
This publication has 17 references indexed in Scilit:
- Implantable transvenous cardioverter-defibrillators.Circulation, 1993
- Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapyJournal of the American College of Cardiology, 1992
- Experience with a New Implantable Pacer-, Cardioverter-Defibrillator for the Therapy of Recurrent Sustained Ventricular Tachyarrhythmias: A Step Toward a Universal Ventricular Tachyarrhythmia Control DevicePacing and Clinical Electrophysiology, 1991
- Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapyJournal of the American College of Cardiology, 1991
- Automatic implantable cardioverter-defibrillator: Is early implantation cost-effective?Journal of the American College of Cardiology, 1990
- Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac diseaseJournal of the American College of Cardiology, 1990
- Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillatorAmerican Heart Journal, 1989
- The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmiasJournal of the American College of Cardiology, 1988
- The automatic implantable cardioverter-defibrillator. Clinical experience, complications, and follow-up in 25 patientsArchives of internal medicine (1960), 1988
- The automatic implantable cardioverter-defibrillator: An overviewJournal of the American College of Cardiology, 1985